NIH

Vanderbilt University has been awarded a prize from the National Institutes of Health for its creation of the LGBTQ+ Policy Lab, which advances a culture of inclusion for sexual and gender minority individuals through interdisciplinary research and collaboration. Read More

An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read More

A multidisciplinary group of investigators from Vanderbilt University Medical Center, Vanderbilt University, and the University of Pennsylvania received a $3.2 million grant to develop novel brain network-based measures to guide surgical decisions and improve outcomes in the field of epilepsy surgery. Read More

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity. Read More

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. Read More

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. Read More

The research team includes, left to right, Bruno Scaglioni, PhD; Keith Obstein MD, MPH; James Martin, PhD; Claire Landewee; Simone Calò, PhD; and Pietro Valdastri, PhD. (photo by Susan Urmy) by Jill Clendening A Vanderbilt Institute for Surgery and Engineering (VISE) research team is conducting the first phase 1 clinical trial of a magnetic, flexible... Read More

New faculty Makayla Cordoza will work with VUMC patients to assess their quality of sleep before and during hospitalization, to better understand how to prevent ICU delirium. Read More

Research led by David Merryman, a professor of biomedical engineering, pharmacology and medicine who holds the Walters Family Chair, has resulted in the development of VU6047534, a new drug that treats pulmonary arterial hypertension—a type of high blood pressure that affects arteries in the lungs and in the heart—without serious neurological side effects. Merryman conducted... Read More

Vanderbilt researchers found reduced net flow of cerebrospinal fluid in Huntington’s disease, which could contribute to mutant protein retention and altered responsiveness to medications delivered via the spinal cord. Read More